4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-25-000177
CIK 0001615219other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:42 PM ET
Size
5.0 KB
Accession
0001615219-25-000177
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Purchase
Common Stock
2025-11-20$0.80/sh+20,000$16,000→ 20,177 total
Footnotes (2)
- [F1]Shares beneficially owned following the transaction is adjusted to reflect the reverse stock splits effective on June 16, 2024 and August 17, 2025.
- [F2]Includes 20 shares of unvested restricted stock granted on January 3, 2023.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:42 PM ET
- Size
- 5.0 KB